Are you Dr. Quon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Andrew Quon, MD is a board certified nuclear medicine physician in Stanford, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care, Lucile Packard Children's Hospital Stanford, and VA Palo Alto Heath Care.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 2000 - 2002
- Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1998 - 1999
- University of Texas Southwestern Medical SchoolClass of 1998
Certifications & Licensure
- CA State Medical License 1999 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI Start of enrollment: 2007 Oct 01
- FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma Start of enrollment: 2017 Sep 07
- Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 3 citationsPrimary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using MidtreatmentF-Fluorodeoxyglucose Posi...Feng-Ming Spring Kong, Chen Hu, Daniel A Pryma, Fenghai Duan, Martha Matuszak
Journal of Clinical Oncology. 2024-11-20 - 1 citationsFAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis.Peter George Maliha, Masatoshi Hotta, Andrea Farolfi, Tristan Grogan, Rejah Alano
European Journal of Nuclear Medicine and Molecular Imaging. 2024-09-01 - 1 citationsIn search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradi...Michelle Jun, Harlan Pinto, Quynh-Thu Le, Andrew Quon, Wendy Hara
Plos One. 2023-01-01
Press Mentions
- Molecular Imaging Pinpoints Source of Chronic Back PainJune 16th, 2011